Supplementary data for: The APOE isoforms differentially shape the transcriptomic and epigenomic landscapes of human microglia in a xenotransplantation model of Alzheimer’s disease. Supplementary_Table1_QC: Excel sheet containing QC metrics for the RNA-seq data and the other containing QC metrics for the ATAC-seq data. Supplementary_Table2_DEGs: Excel sheet containing DeSeq2 differential expression analysis results for the following comparisons: APOE2 vs APOE3, APOE4 vs APOE3, APOE4 vs APOE2, APOE-KO vs APOE3. Supplementary_Table3_DARs: Excel sheet containing DeSeq2 differential accessibility analysis results for the following comparisons: APOE2 vs APOE3, APOE4 vs APOE3, APOE4 vs APOE2, APOE-KO vs APOE3. Supplementary_Table4_MAGMA_geneset_analysis_res: CSV file containing MAGMA gene set analysis results using the differentially expressed genes (FDR < 0.05) for the comparisons outlined in Supplementary_Table2_DEGs and three independent AD GWAS. Supplementary_Table5_sLDSC_res.csv: CSV file containing s-LDSC results using the consensus set of ATAC-seq peaks with three brain disorder GWAS (Alzheimer's disease, autism spectrum disorder, and amyotrophic lateral sclerosis). Supplementary_Table6_WGCNA_clusterProfiler_pathway_enrichment.csv: CSV file containing pathway enrichment results using two WGCNA-identified modules that were significantly upregulated in APOE2-expressing microglia. Supplementary_Table7_homer_motifEnrichment_res.xlsx: Excel sheet containing Homer motif enrichment analysis results using top 100 peaks with increased and decreased chromatin accessibility for APOE2 vs APOE3, APOE4 vs APOE3, and APOE4 vs APOE2.